Paul Campbell Biography and Net Worth

CAO and Corporate Controller of Viatris

Paul Campbell is the Chief Accounting Officer and Corporate Controller of Viatris. He has been with Viatris and its legacy company, Mylan, since 2002.

Paul is a highly practiced leader who is responsible for oversight of the day-to-day operations of the accounting and finance functions of the company, including planning, implementing and managing its finance and accounting activities.

Prior to his current position, Paul served as Mylan’s Chief Accounting Officer, Senior Vice President and Controller, with responsibilities that included overseeing the company’s accounting and financial operations and reporting. He previously held roles of increasing responsibility at the company, including in internal audit, business development, corporate development and operations finance. Paul joined Mylan following a nearly 10-year career at Deloitte & Touche, where he served as Senior Manager in Audit.

Paul earned a Bachelor of Science degree in accounting from The Pennsylvania State University in University Park, Pennsylvania. He also completed the Viatris Executive Leadership Academy at Harvard Business School. He is a member of the Pittsburgh Action Against Rape board of directors.

What is Paul Campbell's net worth?: The estimated net worth of Paul Campbell is at least $1.79 million as of March 5th, 2024. Mr. Campbell owns 153,826 shares of Viatris stock worth more than $1,785,920 as of November 5th. This net worth approximation does not reflect any other investments that Mr. Campbell may own. Learn More about Paul Campbell's net worth.
How old is Paul Campbell?: Mr. Campbell is currently 56 years old. There are 4 older executives and no younger executives at Viatris. Learn More on Paul Campbell's age.
How do I contact Paul Campbell?: The corporate mailing address for Mr. Campbell and other Viatris executives is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. Viatris can also be reached via phone at (724) 514-1800 and via email at [email protected]. Learn More on Paul Campbell's contact information.
Has Paul Campbell been buying or selling shares of Viatris?: Paul Campbell has not been actively trading shares of Viatris in the last ninety days. Most recently, Paul Campbell sold 24,353 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $12.33, for a transaction totalling $300,272.49. Following the completion of the sale, the insider now directly owns 153,826 shares of the company's stock, valued at $1,896,674.58. Learn More on Paul Campbell's trading history.
Who are Viatris' active insiders?: Viatris' insider roster includes Paul Campbell (CAO and Corporate Controller), W. Cornwell (Director), Robert Coury (Chairman), Michael Goettler (CEO), James Kilts (Director), JoElleng Lyons Dillon (Director), Rajiv Malik (Director), Brian Roman (Chief Legal Officer), Menassie Taddese (insider), and Pauline van der Meer Morh (Director). Learn More on Viatris' active insiders.
Are insiders buying or selling shares of Viatris?: During the last twelve months, insiders at the sold shares 15 times. They sold a total of 940,050 shares worth more than $10,904,925.06. The most recent insider tranaction occured on September, 12th when Director Rajiv Malik sold 139,681 shares worth more than $1,628,680.46. Insiders at Viatris own 0.1% of the company. Learn More about insider trades at Viatris.
Information on this page was last updated on 9/12/2024.

Paul Campbell Insider Trading History at Viatris

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/5/2024	Sell	24,353	$12.33	$300,272.49	153,826

Paul Campbell Buying and Selling Activity at Viatris

Viatris Company Overview

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Today's Range

Now: $11.61

$11.33

$11.63

50 Day Range

MA: $11.60

$11.13

$12.08

2 Week Range

Now: $11.61

$8.95

$13.62

Volume

5,300,845 shs

Average Volume

8,546,397 shs

Market Capitalization

$13.86 billion

P/E Ratio

N/A

Dividend Yield

4.13%

Beta

0.93

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Paul Campbell Biography and Net Worth

What is Paul Campbell's net worth?

How old is Paul Campbell?

How do I contact Paul Campbell?

Has Paul Campbell been buying or selling shares of Viatris?

Who are Viatris' active insiders?

Are insiders buying or selling shares of Viatris?